Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias

T315I(+) Philadelphia chromosome–positive leukemias are inherently resistant to all licensed tyrosine kinase inhibitors, and therapeutic options remain limited. We report the outcome of allogeneic stem cell transplantation in 64 patients with documented BCR-ABL(T315I) mutations. Median follow-up was...

Full description

Saved in:
Bibliographic Details
Published in:Blood
Main Authors: Nicolini, Franck Emmanuel, Basak, Grzegorz W., Soverini, Simona, Martinelli, Giovanni, Mauro, Michael J., Müller, Martin C., Hochhaus, Andreas, Chuah, Charles, Dufva, Inge H., Rege-Cambrin, Giovanna, Saglio, Giuseppe, Michallet, Mauricette, Labussière, Hélène, Morisset, Stéphane, Hayette, Sandrine, Etienne, Gabriel, Olavarria, Eduardo, Zhou, Wei, Peter, Senaka, Apperley, Jane F., Cortes, Jorge
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2011
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916555/
https://ncbi.nlm.nih.gov/pubmed/21926354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-367326
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items